Different Midazolam Curve Slopes Limited a Mouse THC Cross-Tolerance Comparison
A mouse THC experiment did not provide one simple null result for every midazolam outcome. Temperature potency was unchanged, but the response-rate curves had significantly different slopes, limiting a straightforward ED50 comparison.
The measurements answered separate questions
Singh and colleagues tested midazolam before and during repeated THC treatment while assessing food-maintained responding and rectal temperature. For temperature, the reported ED50 comparison did not detect a significant change. For responding, the curve during treatment was steeper than the pre-treatment curve.
A midpoint cannot describe every curve difference
An ED50 locates a specified effect level on a dose–response curve. When slopes differ, the relative separation of curves can vary across effect levels. The authors therefore stated that the response-rate ED50 values could not readily be compared. That qualification should remain attached to the result rather than being replaced with an assertion of unchanged sensitivity.
The finding does not establish human sedation risk
These were male mice receiving injected experimental drugs and performing a learned task. The result does not show that cannabis and midazolam are safe together, or that cross-tolerance necessarily occurred. It identifies a limit on the particular comparison. A careful summary reports the temperature null and the response-rate curve limitation separately, preserving what each analysis could establish.
Related analysis: Outcome-specific cannabinoid cross-tolerance.
Research cited
Singh H, Schulze DR, McMahon LR. Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia (2011).
